AEON Biopharma, Inc. Working Capital to Net Assets Ratio
AEON Biopharma, Inc. working capital to net assets ratio. AEON Biopharma, Inc. (AEON) has a Working Capital to Net Assets ratio of 4.1% as of September 2025. Working capital of $-816.00K (current assets of $7.41 Million minus current liabilities of $8.23 Million) is measured against net assets of $-19.87 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See AEON Biopharma, Inc. balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of AEON Biopharma, Inc. (2019–2024)
Working capital to net assets ratio of AEON Biopharma, Inc. from 2019 to 2024. This chart shows how AEON Biopharma, Inc.'s Working Capital to Net Assets ratio has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the ratio stands at 4.1%, reflecting working capital of $-816.00K against net assets of $-19.87 Million USD. See defensive interval ratio of AEON Biopharma, Inc. to measure how many days the company can operate on defensive assets alone.
AEON Biopharma, Inc. Working Capital to Net Assets Ratio by Year (2019–2024)
AEON Biopharma, Inc. working capital to net assets ratio by year from 2019 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for AEON Biopharma, Inc. from 2019 to 2024, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see AEON total asset value.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 44.0% | $-12.56 Million | $-28.57 Million | $1.59 Million | $14.15 Million | ▲ +39.5 pp |
| 2023 | 4.5% | $-6.83 Million | $-153.04 Million | $6.22 Million | $13.05 Million | ▼ -22.4 pp |
| 2022 | 26.9% | $-72.74 Million | $-270.41 Million | $9.84 Million | $82.57 Million | ▲ +19.9 pp |
| 2021 | 7.0% | $-15.65 Million | $-223.82 Million | $5.15 Million | $20.80 Million | ▲ +15.0 pp |
| 2020 | -8.0% | $16.18 Million | $-203.23 Million | $20.38 Million | $4.20 Million | ▲ +135.7 pp |
| 2019 | -143.7% | $94.65 Million | $-65.87 Million | $112.14 Million | $17.50 Million | — |